Related Research Articles
The Delft University of Technology is the oldest and largest Dutch public technical university, located in Delft, The Netherlands. It specializes in engineering, technology, computing, design, and natural sciences.
Peter G. Schultz is an American chemist, entrepreneur, and nonprofit leader. He is the CEO and President and Professor of Chemistry at Scripps Research, the founder and former director of GNF, and the founding director of the California-Skaggs Institute for Innovative Medicines, established in 2012. In August 2014, Nature Biotechnology ranked Schultz the #1 top translational researcher in 2013. Schultz's contributions to the field of chemistry have included the development and application of methods to expand the genetic code of living organisms, the discovery of catalytic antibodies, and the development and application of molecular diversity technologies to address problems in chemistry, biology, and medicine.
Novo Nordisk A/S is a Danish multinational pharmaceutical company headquartered in Bagsværd with production facilities in nine countries and affiliates or offices in five countries. Novo Nordisk is controlled by majority shareholder Novo Holdings A/S which holds approximately 28% of its shares and a majority (77%) of its voting shares.
Novozymes A/S was a global biotechnology company headquartered in Bagsværd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Hans Christian Jacobaeus was a Swedish internist born in Skarhult.
Presented annually since 1991, the Stockholm Water Prize is an award that recognizes outstanding achievements in water related activities. Over the past three decades, Stockholm Water Prize Laureates have come from across the world and represented a wide range of professions, disciplines and activities in the field of water.
Steen Riisgaard is the former president and CEO of the Denmark-based biotech company Novozymes, the world’s largest producer of industrial enzymes. He held this position from when Novozymes was founded in a demerger from Novo Nordisk in 2000 until he left the company in 2013 when Peder Holk Nielsen became CEO.
Hans Christian Hagedorn was the creator of NPH insulin and the founder of Nordisk Insulinlaboratorium, which is known today as Novo Nordisk.
Dame Molly Morag Stevens is the John Black Professor of Bionanoscience at the University of Oxford's Department of Physiology, Anatomy & Genetics. She is Deputy Director of the Kavli Institute for Nanoscience Discovery and a member of the Department for Engineering Science and the Institute for Biomedical Engineering.
Novo Holdings A/S is the Novo Nordisk Foundation's wholly owned holding company for Novo Nordisk A/S and Novozymes A/S. Novo Holdings A/S was established in 1999 and manages the Novo Nordisk Foundation's assets, which in 2023 was worth almost DKK 1,114 billion Danish Kroner. The company generated a total income and investment return of DKK 31 billion in 2023.
Mark van Loosdrecht is a Dutch professor in environmental biotechnology at Delft University of Technology. He was the creator of Nereda, a wastewater treatment technology developed by a cooperation between the Delft University of Technology, the Dutch Foundation for Applied Water Research (STOWA) and Royal HaskoningDHV.
The Novo Nordisk Foundation (NNF) is an international enterprise foundation focusing on medical treatment and research.
Drew Weissman is an American physician and immunologist known for his contributions to RNA biology. Weissman is the inaugural Roberts Family Professor in Vaccine Research, director of the Penn Institute for RNA Innovation, and professor of medicine at the Perelman School of Medicine at the University of Pennsylvania (Penn).
Mads Krogsgaard Thomsen is a Danish businessman, CEO of the Novo Nordisk Foundation and former Executive Vice President of Research & Development, head of R&D and Chief Scientific Officer (CSO) at the pharmaceutical company Novo Nordisk.
The Novo Nordisk Prize is an annual award presented to acknowledge exceptional contributions within the fields of medical and health sciences. It is specifically aimed at individuals who have demonstrated outstanding research or innovation that has the potential to advance medical science, particularly in areas related to diabetes, endocrinology, and biopharmaceutical science. The prize is administered by the Novo Nordisk Foundation, an independent Danish enterprise foundation.
The Hagedorn Prize is an annual award within the field of medical research, specifically recognizing outstanding contributions to diabetes research and endocrinology. Named after Hans Christian Hagedorn, a renowned Danish scientist and co-founder of Nordisk Insulinlaboratorium, the prize celebrates achievements in the understanding and treatment of diabetes.
The Jacobaeus Prize, (also known as the "Jacobæus Prize") is regarded as a prestigious recognition within the field of medical research. It is an annual award given to individuals who have made significant contributions to the advancement of medical science, particularly in the areas of physiology or endocrinology.
The Obesity Prize for Excellence is an international prize awarded annually by the European Association for the Study of Obesity (EASO) in collaboration with the Novo Nordisk Foundation. The prize recognizes extraordinary scientific contributions to obesity research and highlights ground-breaking discoveries that improve the understanding, prevention and treatment of obesity.
The Diabetes Prize for Excellence is an international prize awarded annually by the European Association for the Study of Diabetes (EASD) in collaboration with the Novo Nordisk Foundation. The award recognizes extraordinary research at the intersection of obesity and diabetes and highlights breakthrough discoveries that improve the understanding and treatment of these diseases.
The EFSD/Novo Nordisk Foundation Precision Diabetes Medicine Award is an annual recognition established to support research in the field of precision diabetes medicine. The award is a joint initiative between the European Foundation for the Study of Diabetes (EFSD) and the Novo Nordisk Foundation. Its purpose is to advance the understanding and application of personalised approaches to diabetes care.
References
- ↑ "Novozymes Prize for Biotechnology". TU Delft Research Portal. Retrieved 2024-04-05.
- 1 2 "The Novozymes Prize". Novo Nordisk Fonden. Retrieved 2024-04-05.
- ↑ "Committee on the Novozymes Prize". Novo Nordisk Fonden. Retrieved 2024-04-05.
- ↑ "Prize recipients Archive". Novo Nordisk Fonden. Retrieved 2024-04-05.
- ↑ "Jack Pronk receives the 2024 Novozymes Prize". TU Delft (in Dutch). Archived from the original on 2024-03-29. Retrieved 2025-01-02.
- ↑ "Plant Bioscience". www.pbltechnology.com. Retrieved 2024-04-05.
- ↑ "Plant scientist and poet Anne Osbourn receives prestigious Novozymes Prize". Novo Nordisk Fonden. Retrieved 2024-04-05.
- ↑ Delft University of Technology: Mark van Loosdrecht wins Novozymes Prize for 25 years of revolutionary wastewater treatment https://www.tudelft.nl/en/2022/tnw/mark-van-loosdrecht-wins-novozymes-prize-for-25-years-of-revolutionary-wastewater-treatment
- ↑ Vollmar, Lisa (2021-07-30). "Peer Bork honoured with Novozymes Prize and ISCB Senior Scientist Award". EMBL. Retrieved 2024-04-05.
- ↑ "Weigel, Detlef". www.mpg.de. Retrieved 2024-04-05.
- ↑ "Prize awarded to Professor Dame Carol Robinson for mass spectrometry breakthroughs". ri-vis.eu. Retrieved 2024-04-05.
- ↑ "Professor Dame Carol Robinson wins Novozymes Prize". Exeter College. 2019-03-12. Retrieved 2024-04-05.
- ↑ "Gunnar von Heijne receives The Novozymes Prize". SciLifeLab. 2018-02-26. Retrieved 2024-04-05.
- ↑ "Emmanuelle Charpentier wins Novozomes Prize for CRISPR-Cas9". www.umu.se. Retrieved 2024-04-05.
- ↑ Vilnius University: Novozymes Prize won by researchers behind tools for editing the genes of organisms https://www.vu.lt/en/news-events/news/novozymes-prize-won-by-researchers-behind-tools-for-editing-the-genes-of-organisms